|
|
||||||||
The Annals of Thoracic Surgery, Vol 44, 430-445, Copyright © 1987 by The Society of Thoracic Surgeons
LH Edmunds Jr
A review of articles published since 1979 indicates that thrombotic and
bleeding complications account for about 50% of valve-related complications
in patients with bioprosthetic aortic and mitral valves and for
approximately 75% of the complications in patients with mechanical valves.
Although compromised by lack of standard definitions and by variability in
reporting and follow-up, the data suggest that the linearized rate of both
thrombotic and bleeding complications in patients with aortic bioprostheses
is approximately half that for aortic mechanical prostheses (2% versus 4%),
but is approximately equal for both bioprostheses and mechanical valves in
the mitral position (approximately 4%), and for mechanical and
bioprosthetic aortic and mitral valves in combination. However, linearized
rates for fatal thrombotic and bleeding events are two to four times higher
in patients with mechanical prostheses. The adequacy of warfarin
anticoagulation is the most important factor affecting thrombotic and
bleeding complications in patients with mechanical valves and over shadows
the dubious importance of other phenomena such as atrial fibrillation and
left atrial thrombus. Short-term warfarin anticoagulation or the use of
long-term platelet inhibitors, or both, do not appear to reduce the
incidence of thrombotic complications in patients with aortic bioprostheses
but increase bleeding. For mitral bioprostheses, the postoperative use of
warfarin for three months or aspirin indefinitely is as effective in
preventing thromboembolism as long-term warfarin. Acute prosthetic valve
endocarditis is associated with a 13 to 40% incidence of thrombotic
complications. Likewise, the recurrence rate of cerebral emboli is high
(20-30%) in patients with prosthetic valves who are not anticoagulated.
Bioprostheses are strongly preferred for women who wish to bear children;
fetal wastage occurs in 25 to 30% of pregnant women with mechanical heart
valves who receive either warfarin or heparin, or a combination of the two.
Heparin, however, greatly increases the risk of maternal bleeding. In
children, the efficacy of platelet inhibitors without warfarin
anticoagulation is unproven; nearly all serious strokes occur when warfarin
is omitted; and permanent disability from warfarin-related bleeding is
rare. All prosthetic cardiac valves initiate coagulation and affect the
dynamic equilibrium between activated procoagulants and endogenous
anticoagulants. Warfarin is the only available oral exogenous
anticoagulant.(ABSTRACT TRUNCATED AT 400 WORDS)
ARTICLES
Thrombotic and bleeding complications of prosthetic heart valves
Department of Surgery, University of Pennsylvania, Philadelphia 19104.
This article has been cited by other articles:
![]() |
M. Skjelland, A. Michelsen, F. Brosstad, J. L. Svennevig, R. Brucher, and D. Russell Solid Cerebral Microemboli and Cerebrovascular Symptoms in Patients With Prosthetic Heart Valves Stroke, April 1, 2008; 39(4): 1159 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Desai and G. T. Christakis Bioprosthetic Aortic Valve Replacement: Stented Pericardial and Porcine Valves Card. Surg. Adult, January 1, 2008; 3(2008): 857 - 894. [Full Text] |
||||
![]() |
J. P. Greelish, R. M. Ahmad, J. M. Balaguer, M. R. Petracek, and J. G. Byrne Reoperative Valve Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 1159 - 1174. [Full Text] |
||||
![]() |
M. Brueck, W. Kramer, P. Vogt, N. Steinert, P. Roth, G. Gorlach, M. Schonburg, and M. C. Heidt Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 108 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pengo, G. Palareti, U. Cucchini, M. Molinatti, R. Del Bono, F. Baudo, A. Ghirarduzzi, C. Pegoraro, and S. Iliceto Low-Intensity Oral Anticoagulant Plus Low-Dose Aspirin During the First Six Months Versus Standard-Intensity Oral Anticoagulant Therapy After Mechanical Heart Valve Replacement: A Pilot Study of Low-Intensity Warfarin and Aspirin in Cardiac Prostheses (LIWACAP) Clinical and Applied Thrombosis/Hemostasis, July 1, 2007; 13(3): 241 - 248. [Abstract] [PDF] |
||||
![]() |
C. Nyboe, J. A. Funder, M. H. Smerup, H. Nygaard, and J. M. Hasenkam Turbulent stress measurements downstream of three bileaflet heart valve designs in pigs. Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 1008 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kulik, F. D. Rubens, P. S. Wells, C. Kearon, T. G. Mesana, J. van Berkom, and B.-K. Lam Early Postoperative Anticoagulation After Mechanical Valve Replacement: A Systematic Review Ann. Thorac. Surg., February 1, 2006; 81(2): 770 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Guenzinger, W. B. Eichinger, F. Botzenhardt, S. Bleiziffer, I. Wagner, R. Bauernschmitt, S. M. Wildhirt, and R. Lange Rest and Exercise Performance of the Medtronic Advantage Bileaflet Valve in the Aortic Position Ann. Thorac. Surg., October 1, 2005; 80(4): 1319 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kallenbach, T. Oelze, R. Salcher, C. Hagl, M. Karck, R. G. Leyh, and A. Haverich Evolving Strategies for Treatment of Acute Aortic Dissection Type A Circulation, September 14, 2004; 110(11_suppl_1): II-243 - II-249. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Butchart and C. Gohlke-Barwolf Anticoagulation management of patients with prosthetic valves J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1143 - 1144. [Full Text] [PDF] |
||||
![]() |
D. D. Potter, T. M. Sundt III, K. J. Zehr, J. A. Dearani, R. C. Daly, C. J. Mullany, C. G. A. McGregor, F. J. Puga, H. V. Schaff, and T. A. Orszulak Risk of repeat mitral valve replacement for failed mitral valve prostheses Ann. Thorac. Surg., July 1, 2004; 78(1): 67 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Butchart, A. Ionescu, N. Payne, J. Giddings, G. L. Grunkemeier, and A. G. Fraser A New Scoring System to Determine Thromboembolic Risk After Heart Valve Replacement Circulation, September 9, 2003; 108(90101): II-68 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Koertke, K. Minami, D. Boethig, Th. Breymann, D. Seifert, O. Wagner, N. Atmacha, A. Krian, J. Ennker, U. Taborski, et al. INR Self-Management Permits Lower Anticoagulation Levels After Mechanical Heart Valve Replacement Circulation, September 9, 2003; 108(90101): II-75 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Chong, D. E. Alejo, P. S. Greene, J. M. Redmond, M. S. Sussman, W. A. Baumgartner, and D. E. Cameron Cardiac valve replacement in human immunodeficiency virus-infected patients Ann. Thorac. Surg., August 1, 2003; 76(2): 478 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Desai and G. T. Christakis Stented Mechanical/Bioprosthetic Aortic Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 825 - 856. [Full Text] |
||||
![]() |
T. Gudbjartsson, S. Aranki, and L. H. Cohn Mechanical/Bioprosthetic Mitral Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 951 - 986. [Full Text] |
||||
![]() |
J. G. Byrne, B. J. Phillips, and L. H. Cohn Reoperative Valve Surgery Card. Surg. Adult, January 1, 2003; 2(2003): 1047 - 1056. [Full Text] |
||||
![]() |
K. Kallenbach, C. Hagl, T. Walles, R. G. Leyh, K. Pethig, A. Haverich, and W. Harringer Results of valve-sparing aortic root reconstruction in 158 consecutive patients Ann. Thorac. Surg., December 1, 2002; 74(6): 2026 - 2033. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kallenbach, K. Pethig, R.G. Leyh, D. Baric, A. Haverich, and W. Harringer Acute dissection of the ascending aorta: first results of emergency valve sparing aortic root reconstruction Eur. J. Cardiothorac. Surg., August 1, 2002; 22(2): 218 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Clarke Presidential address: Value, viability, and valves J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 1 - 6. [Full Text] [PDF] |
||||
![]() |
T. Ohata, T. Sakakibara, H. Takano, and T. Ishizaka Acute Thrombotic Obstruction of Mitral Valve Prosthesis: Low Protein C Level Asian Cardiovasc Thorac Ann, June 1, 2002; 10(2): 165 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Erdil, L. Cetin, V. Nisanoglu, E. Sener, and U. Demirkilic Cardiopulmonary Bypass Before General Anesthesia in Prosthetic Valve Thrombosis Asian Cardiovasc Thorac Ann, March 1, 2002; 10(1): 83 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pethig, A. Milz, C. Hagl, W. Harringer, and A. Haverich Aortic valve reimplantation in ascending aortic aneurysm: risk factors for early valve failure Ann. Thorac. Surg., January 1, 2002; 73(1): 29 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Huth, A. Friedl, A. Rost, and for the GELIA Study Investigator Group Intensity of oral anticoagulation after implantation of St. Jude Medical aortic prosthesis: analysis of the GELIA Database (GELIA 4) Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q33 - Q38. [Abstract] [PDF] |
||||
![]() |
H. Kortke and R. Korfer International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann. Thorac. Surg., July 1, 2001; 72(1): 44 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kallenbach, K. Pethig, M. Schwarz, A. Milz, A. Haverich, and W. Harringer Valve sparing aortic root reconstruction versus composite replacement - perioperative course and early complications Eur. J. Cardiothorac. Surg., July 1, 2001; 20(1): 77 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hofmann, R. Cichon, M. Knaut, U. Kappert, S. M. Tugtekin, W. Aron, and S. Schuler Early experience with a quadrileaflet stentless mitral valve Ann. Thorac. Surg., May 1, 2001; 71 (2007): S323 - S326. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Casselman, M. L. Bots, W. Van Lommel, P. J. Knaepen, R. Lensen, and F. E.E. Vermeulen Repeated thromboembolic and bleeding events after mechanical aortic valve replacement Ann. Thorac. Surg., April 1, 2001; 71(4): 1172 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walther, V. Falk, C. Walther, B. Krauss, G. Hindricks, H. Kottkamp, M. Kostelka, A. Diegeler, R. Autschbach, and F. W. Mohr Combined stentless mitral valve implantation and radiofrequency ablation Ann. Thorac. Surg., September 1, 2000; 70(3): 1080 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Vogt, H.-P. Brunner-LaRocca, P. Sidler, G. Zund, K. Truniger, M. Lachat, J. Turina, and M. I. Turina Reoperative surgery for degenerated aortic bioprostheses: predictors for emergency surgery and reoperative mortality Eur. J. Cardiothorac. Surg., February 1, 2000; 17(2): 134 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walther, C. Walther, V. Falk, A. Diegeler, R. Krakor, J. Schneider, R. Autschbach, and F. W. Mohr Early Clinical Results After Stentless Mitral Valve Implantation and Comparison With Conventional Valve Repair or Replacement Circulation, November 9, 1999; 100(90002): II-78 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nitta, Y. Ishii, H. Ogasawara, S. Sakamoto, Y. Miyagi, K. Yamada, S. Kanno, and S. Tanaka Initial experience with the radial incision approach for atrial fibrillation Ann. Thorac. Surg., September 1, 1999; 68(3): 805 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Chessa, R. Dekker, B. Van Vliet, E. W. Steyerberg, and J. D. F. Habbema Correlations in Uncertainty Analysis for Medical Decision Making: An Application to Heart-valve Replacement Med Decis Making, August 1, 1999; 19(3): 276 - 286. [Abstract] [PDF] |
||||
![]() |
C. Guglielmi, G. Toscano, V. Pistorio, I. Vendramin, T. Bottio, G. Thiene, and D. Casarotto Reoperations for acute prosthetic thrombosis and pannus: an assessment of rates, relationship and risk Eur. J. Cardiothorac. Surg., July 1, 1999; 16(1): 74 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Emir, G. Uzunonat, B. Yamak, A T. Ulus, M K. Gol, Z. Iscan, S F. Katircioglu, B. Mavitas, O. Tasdemir, and K. Bayazit Effects of Pregnancy on Long-Term Follow-Up of Mitral Valve Bioprostheses Asian Cardiovasc Thorac Ann, September 1, 1998; 6(3): 174 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jaggers, J. K. Harrison, T. M. Bashore, R. D. Davis, D. D. Glower, and R. M. Ungerleider The Ross Procedure: Shorter Hospital Stay, Decreased Morbidity, and Cost Effective Ann. Thorac. Surg., June 1, 1998; 65(6): 1553 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barbero, V. Pengo, and G. Fasoli Fatal Cerebral Hemorrhage Complicating Thromboembolic Stroke in a Patient with Prosthetic Mitral Valve Thrombosis Treated with Thrombolytic Therapy Clinical and Applied Thrombosis/Hemostasis, October 1, 1997; 3(4): 290 - 293. [Abstract] [PDF] |
||||
![]() |
S. M. Bradley, R. M. Sade, F. A. Crawford Jr, and M. R. Stroud Anticoagulation in Children With Mechanical Valve Prostheses Ann. Thorac. Surg., July 1, 1997; 64(1): 30 - 34. [Abstract] [Full Text] |
||||
![]() |
C. Giansante, N. Fiotti, S. Calabrese, R. La Verde, C. Pandullo, S. Scardi, and G. Guarnieri D-Dimer and Anticoagulation in Patients With Mechanical Prosthetic Heart Valves : A 2-Year Follow-up Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1320 - 1324. [Abstract] [Full Text] |
||||
![]() |
N. Vitale, A. Renzulli, L. Agozzino, A. Pollice, N. Tedesco, L. d. L. T. Schinosa, and M. Cotrufo Obstruction of Mechanical Mitral Prostheses: Analysis of Pathologic Findings Ann. Thorac. Surg., April 1, 1997; 63(4): 1101 - 1106. [Abstract] [Full Text] |
||||
![]() |
D. P. O'Hair, E. A. Rose, and C. W. Akins Mechanical Valve Performance Ann. Thorac. Surg., November 1, 1996; 62(5): 1570 - 1571. [Full Text] |
||||
![]() |
A. A. Mikhail and C. W. Akins Omniscience Valve Evolution and Literature Ann. Thorac. Surg., August 1, 1996; 62(2): 624 - 626. [Full Text] |
||||
![]() |
P. Simon, A. Mortiz, R. Moidl, N. Kupilik, M. Grabenwoeger, M. Ehrlich, and M. Havel Aortic Valve Resuspension in Ascending Aortic Aneurysm Repair With Aortic Insufficiency Ann. Thorac. Surg., July 1, 1995; 60(1): 176 - 180. [Abstract] [Full Text] |
||||
![]() |
S. K. Brękken, D. Russell, R. Brucher, and J. Svennevig Incidence and Frequency of Cerebral Embolic Signals in Patients With a Similar Bileaflet Mechanical Heart Valve Stroke, July 1, 1995; 26(7): 1225 - 1230. [Abstract] [Full Text] |
||||
![]() |
H. J.M. Barnett, M. Eliasziw, and H. E. Meldrum Drugs and Surgery in the Prevention of Ischemic Stroke N. Engl. J. Med., January 26, 1995; 332(4): 238 - 248. [Full Text] [PDF] |
||||
![]() |
D. D. Glower, W. D. White, A. C. Hatton, L. R. Smith, W. G. Young, W. G. Wolfe, and J. E. Lowe Determinants of reoperation after 960 valve replacements with Carpentier-Edwards prostheses J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 381 - 393. [Abstract] [Full Text] |
||||
![]() |
H. Nygaard, P. K. Paulsen, J. M. Hasenkam, E. M. Pedersen, and P. E. Rovsing Turbulent stresses downstream of three mechanical aortic valve prostheses in human beings J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 438 - 446. [Abstract] [Full Text] |
||||
![]() |
N. T. Kouchoukos, V. G. Davila-Roman, T. L. Spray, S. F. Murphy, and J. B. Perrillo Replacement of the Aortic Root with a Pulmonary Autograft in Children and Young Adults with Aortic-Valve Disease N. Engl. J. Med., January 6, 1994; 330(1): 1 - 6. [Abstract] [Full Text] |
||||
![]() |
Cardiogenic Brain Embolism: The Second Report of the Cerebral Embolism Task Force Arch Neurol, July 1, 1989; 46(7): 727 - 743. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |